In recent years, Lupin has seen several ups and downs as it has grappled with quality issues across its organization, particularly when it comes to ensuring that its facilities comply with US Food and Drug Administration standards.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?